BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'

Go back to BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'

Crocs (CROX) PT Lowered to $138 at Stifel, 'Brand and Improving Balance Sheet Support Risk/Reward'

October 30, 2024 7:00 AM EDT

Stifel analyst Jim Duffy lowered the price target on Crocs (NASDAQ: CROX) to $138.00 (from $158.00) while maintaining a Buy rating.

The analyst comments "3Q24 revenue (+$16mn) and adj. EPS upside (+$0.52) benefited from a pull-forward of wholesale orders, and 4Q24 revenue and adj.... More

Raymond James Downgrades Crocs (CROX) to Market Perform

October 30, 2024 6:25 AM EDT

Raymond James analyst Rick Patel downgraded Crocs (NASDAQ: CROX) from Outperform to Market Perform.


For an analyst ratings summary and ratings history on Crocs click here. For more ratings news on Crocs click here.


Shares of Crocs closed at $111.58 yesterday.

... More

Crocs (CROX) PT Lowered to $150 at KeyBanc

October 30, 2024 2:22 AM EDT

KeyBanc analyst Ashley Owens lowered the price target on Crocs (NASDAQ: CROX) to $150.00 (from $155.00) while maintaining a Overweight rating.... More

Crocs (CROX) PT Lowered to $125 at Barclays

October 29, 2024 2:36 PM EDT

Barclays analyst Adrienne Yih lowered the price target on Crocs (NASDAQ: CROX) to $125.00 (from $164.00) while maintaining a Overweight rating.

The analyst comments "3Q24 results beat expectations on sales, OM, and EPS, mostly driven by SG&A leverage. Despite the... More

Crocs (CROX) PT Lowered to $140 at Williams Trading

October 29, 2024 2:21 PM EDT

Williams Trading analyst Sam Poser lowered the price target on Crocs (NASDAQ: CROX) to $140.00 (from $163.00) while maintaining a Buy rating.

The analyst comments "Lowering PT from $163 to $140, raising FY24 estimates, lowering FY25 estimates, and introducing FY26 estimates. The better than expected 3Q24 results were driven by a 7.5% increase in Crocs revenue, which beat consensus by 2.5%,... More

Crocs shares slide after shoe retailer tempers full-year sales outlook

October 29, 2024 7:49 AM EDT

Investing.com -- Shares in Crocs (NASDAQ: CROX) sank in premarket US trading on Tuesday after the shoe seller tempered its full-year revenue guidance due to weakness at its Hey Dude casual footwear brand.

Crocs said it now expects to report annual revenue growth... More

Crocs (CROX) Tops Q3 EPS by 50c; offers guidance

October 29, 2024 7:02 AM EDT

Crocs (NASDAQ: CROX) reported Q3 EPS of $3.60, $0.50 better than the analyst estimate of $3.10. Revenue for the quarter came in at $1.06 billion versus the consensus estimate of $1.05 billion.

GUIDANCE:

Crocs sees Q4 2024 EPS of $2.20-$2.28, versus the consensus of... More